DK1435985T3 - Lægemiddel indeholdende aktiveret antithrombin III - Google Patents

Lægemiddel indeholdende aktiveret antithrombin III

Info

Publication number
DK1435985T3
DK1435985T3 DK01969710T DK01969710T DK1435985T3 DK 1435985 T3 DK1435985 T3 DK 1435985T3 DK 01969710 T DK01969710 T DK 01969710T DK 01969710 T DK01969710 T DK 01969710T DK 1435985 T3 DK1435985 T3 DK 1435985T3
Authority
DK
Denmark
Prior art keywords
drug containing
antithrombin iii
containing activated
activated antithrombin
iii
Prior art date
Application number
DK01969710T
Other languages
English (en)
Inventor
Beate Kehrel
Martin Brodde
Original Assignee
Beate Kehrel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beate Kehrel filed Critical Beate Kehrel
Application granted granted Critical
Publication of DK1435985T3 publication Critical patent/DK1435985T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • AIDS & HIV (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK01969710T 2000-09-12 2001-09-12 Lægemiddel indeholdende aktiveret antithrombin III DK1435985T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10045047A DE10045047A1 (de) 2000-09-12 2000-09-12 Arzneimittel enthaltend aktiviertes Antithrombin III
PCT/EP2001/010541 WO2002022150A2 (de) 2000-09-12 2001-09-12 Arzneimittel enthaltend aktiviertes antithrombin iii

Publications (1)

Publication Number Publication Date
DK1435985T3 true DK1435985T3 (da) 2007-08-20

Family

ID=7655909

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01969710T DK1435985T3 (da) 2000-09-12 2001-09-12 Lægemiddel indeholdende aktiveret antithrombin III

Country Status (14)

Country Link
US (2) US7388075B2 (da)
EP (1) EP1435985B1 (da)
JP (1) JP5517387B2 (da)
AP (1) AP2049A (da)
AT (1) ATE359085T1 (da)
AU (2) AU8987601A (da)
CY (1) CY1106657T1 (da)
DE (2) DE10045047A1 (da)
DK (1) DK1435985T3 (da)
ES (1) ES2283432T3 (da)
NZ (1) NZ525292A (da)
PT (1) PT1435985E (da)
WO (1) WO2002022150A2 (da)
ZA (1) ZA200302907B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1328289B1 (de) * 2000-10-20 2008-09-03 Hamburger Stiftung zur Förderung von Wissenschaft und Kultur Oxidierte proteine und deren biologische und therapeutische aktivität sowie diagnostische verwendung über die hemmung der interaktion zwischen oxidierten proteinen und cd36
DE10051983A1 (de) * 2000-10-20 2002-06-13 Beate Kehrel Inhibierung der pathogenen Wirkung oxidierter Proteine
DE10102048A1 (de) * 2001-01-17 2002-07-18 Aventis Behring Gmbh Antithrombin III gegen durch Angiogenese verursachte Krankheiten
CA2480790A1 (en) * 2002-04-01 2003-10-16 Kazunori Murakami Use of antithrombin iii in treating acute lung injury
ES2375601T3 (es) * 2003-04-25 2012-03-02 Hamburger Stiftung Zur Förderung Von Wissenschaft Und Kultur Lucha contra infecciones por virus de ih con plasma sangu�?neo humano oxidado con �?cido hipocloroso.
EP2069477A4 (en) * 2006-10-06 2010-12-08 Celtaxsys Inc Chemorepulsion of cells
JP2010235447A (ja) * 2007-07-30 2010-10-21 Igaku Seibutsugaku Kenkyusho:Kk 炎症性サイトカインの抑制剤
DE102011003936A1 (de) 2011-02-10 2012-08-16 Oxprotect Gmbh Verwendung von Proteinen/Peptiden, welche an GRP78 (BIP) binden, in Labormethoden zum Monitoring von Thrombozyten-Aggregationshemmern
EP2956003A2 (en) 2013-02-13 2015-12-23 Laboratoire Français du Fractionnement et des Biotechnologies Proteins with modified glycosylation and methods of production thereof
WO2017149391A1 (en) * 2016-03-02 2017-09-08 Laboratoire Francais Du Fractionnement Et Des Biotechnologies The use of antithrombin for coating organs during transplantation
EP4311556A1 (en) * 2022-07-28 2024-01-31 Grifols Worldwide Operations Limited Antithrombin in stroke

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2739050B2 (ja) * 1988-01-28 1998-04-08 ヘキスト薬品工業株式会社 抗血液凝固剤
DE4311580C1 (de) 1993-04-12 1994-08-18 Werner Prof Dr Med Reutter Glycoproteine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel
JP3820607B2 (ja) * 1995-11-10 2006-09-13 三菱ウェルファーマ株式会社 アンチトロンビン−ｉｉｉの液状製剤およびその保存安定化方法
US6686303B1 (en) * 1998-11-13 2004-02-03 Kimberly-Clark Worldwide, Inc. Bicomponent nonwoven webs containing splittable thermoplastic filaments and a third component
DE19852729A1 (de) * 1998-11-16 2000-05-18 Werner Reutter Rekombinante Glycoproteine, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und ihre Verwendung
EP1027894A3 (en) * 1999-01-28 2001-01-24 Aventis Behring Gesellschaft mit beschränkter Haftung Pharmaceutical preparation for the treatment of inflammatory processes
US20020127698A1 (en) * 2001-01-26 2002-09-12 Ralf Geiben Lynn Serpin drugs for treatment of HIV infection and method of use thereof

Also Published As

Publication number Publication date
AP2003002783A0 (en) 2003-06-30
WO2002022150A2 (de) 2002-03-21
EP1435985A2 (de) 2004-07-14
CY1106657T1 (el) 2012-01-25
US8114840B2 (en) 2012-02-14
ZA200302907B (en) 2003-09-15
US20090036360A1 (en) 2009-02-05
DE10045047A1 (de) 2002-03-21
AP2049A (en) 2009-09-25
WO2002022150A3 (de) 2004-05-06
DE50112350D1 (de) 2007-05-24
EP1435985B1 (de) 2007-04-11
US20040029799A1 (en) 2004-02-12
AU8987601A (en) 2002-03-26
JP2004518625A (ja) 2004-06-24
ATE359085T1 (de) 2007-05-15
PT1435985E (pt) 2007-07-11
AU2001289876B2 (en) 2006-09-07
NZ525292A (en) 2005-08-26
ES2283432T3 (es) 2007-11-01
JP5517387B2 (ja) 2014-06-11
US7388075B2 (en) 2008-06-17

Similar Documents

Publication Publication Date Title
ATE311915T1 (de) Medikamentenspender
IS6686A (is) Hýdrógel-drifið lyfjaskömmtunarform
DK1524266T3 (da) Farmaceutisk sammensætning
DE60126272D1 (de) Feststellkatheter
DE50113985D1 (de) Halterung
NO20003968D0 (no) Farmasøytiske preparater
EP1296698A4 (en) THERAPEUTIC AGENTS - II
AT7729U3 (de) Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
DE60113214D1 (de) Plattierungsbadanalyse
PL364773A1 (pl) Inhalator dozujący ksynafonian salmeterolu
MXPA03001425A (es) Compuestos farmaceuticos.
EP1264611A4 (en) SYRINGE
DE60032946D1 (de) Katheter
ATE366128T1 (de) Pharmazeutische zusammensetzung
DE50112350D1 (de) Arzneimittel enthaltend aktiviertes antithrombin iii
DE10196460T1 (de) Selbstzerstör-Spritze
DE50113112D1 (de) Schaltungsanordnung
DE60134742D1 (de) Selbstentfaltbare katheteranordung
FI4651U1 (fi) Kaivo
FR2805803B1 (fr) Monte-materiaux
FI20001398L (fi) Kaivo
DE50115426D1 (de) Schaltungsanordnung
SE0004584D0 (sv) Leveransenhet
SE0001240D0 (sv) Injektionsspruta
UA4638S (uk) Шприц